These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3876685)

  • 41. Trimer and tetramer complexes containing C1 esterase inhibitor, C1r and C1s, in serum and synovial fluid of patients with rheumatic disease.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol Methods; 1990 May; 129(1):55-61. PubMed ID: 2338498
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Concentrations of C1q, factor B, factor D and properdin in healthy children, and the age-related presence of circulating C1r-C1s complexes.
    Prellner K; Sjöholm AG; Truedsson L
    Acta Paediatr Scand; 1987 Nov; 76(6):939-43. PubMed ID: 2827430
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The unactivated form of the first component of human complement, C1.
    Gigli I; Porter RR; Sim RB
    Biochem J; 1976 Sep; 157(3):541-8. PubMed ID: 985398
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neutron scattering studies of subcomponent C1q of first component C1 of human complement and its association with subunit C1r2C1s2 within C1.
    Perkins SJ; Villiers CL; Arlaud GJ; Boyd J; Burton DR; Colomb MG; Dwek RA
    J Mol Biol; 1984 Nov; 179(3):547-57. PubMed ID: 6096553
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
    Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
    J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A molecular mechanism for the activation of the first component of complement by immune complexes.
    Schumaker VN; Hanson DC; Kilchherr E; Phillips ML; Poon PH
    Mol Immunol; 1986 May; 23(5):557-65. PubMed ID: 3018553
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reconstitution of C1 in native proenzyme form and its use in a quantitative C1 activation test.
    Cooper NR; Ziccardi RJ
    J Immunol; 1977 Nov; 119(5):1664-7. PubMed ID: 915274
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lack of activation of C1, despite circulating immune complexes detected by two C1q methods, in patients with rheumatoid arthritis.
    Hack CE; Eerenberg-Belmer AJ; Lim UG; Haverman J; Aalberse RC
    Arthritis Rheum; 1984 Jan; 27(1):40-8. PubMed ID: 6318777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biosynthesis of the subcomponents C1q, C1r and C1s of the first component of complement (C1) by guinea pig hepatocyte primary cultures.
    Ramadori G; Heinz HP; Martin H; Meyer zum Büschenfelde KH; Loos M
    Eur J Immunol; 1986 Sep; 16(9):1137-41. PubMed ID: 3019707
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Calcium binding properties of the C1 subcomponents C1q, C1r and C1s.
    Villiers CL; Arlaud GJ; Painter RH; Colomb MG
    FEBS Lett; 1980 Aug; 117(1):289-94. PubMed ID: 6250896
    [No Abstract]   [Full Text] [Related]  

  • 51. Co-operative interaction of subcomponents of the first component of complement with IgG: a functional defect of dimeric Facb from rabbit IgG.
    Okada M; Udaka K; Utsumi S
    Mol Immunol; 1985 Dec; 22(12):1399-406. PubMed ID: 3007976
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitation of (C1INH)2 C1r-C1s complexes in glomerulonephritis as an indicator of C1 activation.
    Waldo FB; West CD
    Clin Immunol Immunopathol; 1987 Feb; 42(2):239-49. PubMed ID: 3026704
    [TBL] [Abstract][Full Text] [Related]  

  • 53. X-ray structure of the Ca2+-binding interaction domain of C1s. Insights into the assembly of the C1 complex of complement.
    Gregory LA; Thielens NM; Arlaud GJ; Fontecilla-Camps JC; Gaboriaud C
    J Biol Chem; 2003 Aug; 278(34):32157-64. PubMed ID: 12788922
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of immune complexes in the activation of the first component of human complement.
    Ziccardi RJ
    J Immunol; 1984 Jan; 132(1):283-8. PubMed ID: 6317744
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The human complement C1 complex has a picomolar dissociation constant at room temperature.
    Tseng Y; Zavodszky P; Schumaker VN
    J Immunol; 1997 Jan; 158(2):937-44. PubMed ID: 8993014
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A monoclonal antibody to C1q which appears to interact with C1r2C1s2-binding site.
    Hsiung L; Dodds AW; Mason DW; Reid KB
    FEBS Lett; 1988 Feb; 229(1):21-4. PubMed ID: 2831088
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Complement activation, circulating C1q binding substances and inflammatory activity in rheumatoid arthritis: relations and changes on suppression of inflammation.
    Berglund K; Laurell AB; Nived O; Sjoholm AG; Sturfelt G
    J Clin Lab Immunol; 1980 Jul; 4(1):7-14. PubMed ID: 7463476
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Beta-amyloid fibrils activate the C1 complex of complement under physiological conditions: evidence for a binding site for A beta on the C1q globular regions.
    Tacnet-Delorme P; Chevallier S; Arlaud GJ
    J Immunol; 2001 Dec; 167(11):6374-81. PubMed ID: 11714802
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characteristics of complement subcomponents C1r and C1s synthesized by Hep G2 cells.
    Reboul A; Bensa JC; Colomb MG
    Biochem J; 1986 Jan; 233(2):559-64. PubMed ID: 3006672
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biosynthesis in vitro of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytes.
    Bensa JC; Reboul A; Colomb MG
    Biochem J; 1983 Nov; 216(2):385-92. PubMed ID: 6318736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.